Abstract
Alzheimer's Disease (AD) is an invalidating neurodegenerative disorders frequently affecting the aging population. In view of the increase of elderlies, not only in western countries, the related growing societal problems urge for identifying clinical biomarkers in view of potential treatments interfering or blocking the disease course. Among the plenty of anatomo-functional in vivo imaging techniques to inspect brain circuits and physiology, the Magnetic Resonance Imaging (MRI), the functional MRI (fMRI), the Electroencephalography (EEG) and Magnetoencephalography (MEG), have been extensively used for the study of AD, with different achievements and limitations. Eventually, the methodologies summoned by brain connectomics further strengthen the expectations in this field, as shown by recent results obtained with [18F]2-fluoro-2-deoxyglucose 18FDG-PET and fMRI in the prediction of the AD in early stages. However, the inherent complexity of the pathophysiology of the AD suggests that only integrative approaches combining different techniques and methodologies of brain scanning could produce significant breakthroughs in the study of AD. This review proposes a formal framework able to combine brain connectomic data from multimodal acquisitions by means of different in vivo neuroimaging techniques, briefly reporting their different advantages and drawbacks. Indeed, a specialized complex multiplex network, where nodes interact in layers linking the same pair of nodes and each layer reflects a distinct type of brain acquisition, can model the plurality of connectomes recommended in this framework.
Keywords: Alzheimer’s Disease, fMRI, MRI, PET, EEG, multiplex networks, brain connectomes, high-resolution multimodal scanner.
Current Alzheimer Research
Title:Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease
Volume: 13 Issue: 5
Author(s): Antonio Giuliano Zippo and Isabella Castiglioni
Affiliation:
Keywords: Alzheimer’s Disease, fMRI, MRI, PET, EEG, multiplex networks, brain connectomes, high-resolution multimodal scanner.
Abstract: Alzheimer's Disease (AD) is an invalidating neurodegenerative disorders frequently affecting the aging population. In view of the increase of elderlies, not only in western countries, the related growing societal problems urge for identifying clinical biomarkers in view of potential treatments interfering or blocking the disease course. Among the plenty of anatomo-functional in vivo imaging techniques to inspect brain circuits and physiology, the Magnetic Resonance Imaging (MRI), the functional MRI (fMRI), the Electroencephalography (EEG) and Magnetoencephalography (MEG), have been extensively used for the study of AD, with different achievements and limitations. Eventually, the methodologies summoned by brain connectomics further strengthen the expectations in this field, as shown by recent results obtained with [18F]2-fluoro-2-deoxyglucose 18FDG-PET and fMRI in the prediction of the AD in early stages. However, the inherent complexity of the pathophysiology of the AD suggests that only integrative approaches combining different techniques and methodologies of brain scanning could produce significant breakthroughs in the study of AD. This review proposes a formal framework able to combine brain connectomic data from multimodal acquisitions by means of different in vivo neuroimaging techniques, briefly reporting their different advantages and drawbacks. Indeed, a specialized complex multiplex network, where nodes interact in layers linking the same pair of nodes and each layer reflects a distinct type of brain acquisition, can model the plurality of connectomes recommended in this framework.
Export Options
About this article
Cite this article as:
Zippo Giuliano Antonio and Castiglioni Isabella, Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/1567205013666151116142451
DOI https://dx.doi.org/10.2174/1567205013666151116142451 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
CNS & Neurological Disorders - Drug Targets Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals
Current Topics in Medicinal Chemistry Animal Models in Neurology: Drawbacks and Opportunities
Current Pharmaceutical Design Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design The Role of Saffron in Attenuating Age-related Oxidative Damage in Rat Hippocampus
Recent Patents on Food, Nutrition & Agriculture Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease
Current Drug Metabolism A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Bacteriophage - A Common Divergent Therapeutic Approach for Alzheimer's Disease and Type II Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Differential Effects of Nicotine Exposure on the Hippocampus Across Lifespan
Current Neuropharmacology Microglial Senescence
CNS & Neurological Disorders - Drug Targets The Emory Chemical Biology Discovery Center: Leveraging Academic Innovation to Advance Novel Targets through HTS and Beyond
Combinatorial Chemistry & High Throughput Screening Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Targets PRAS40 to Govern β-Amyloid Apoptotic Injury of Microglia
Current Neurovascular Research Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies
Medicinal Chemistry The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Current Molecular Pharmacology Organophosphate Induced Delayed Polyneuropathy
Medicinal Chemistry Reviews - Online (Discontinued) Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease
Current Alzheimer Research Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders
Central Nervous System Agents in Medicinal Chemistry Modern Pathology: Protein Mis-Folding and Mis-Processing in Complex Disease
Current Protein & Peptide Science